Skip to main content
ARROWHEAD PHARMACEUTICALS, INC. logo

ARROWHEAD PHARMACEUTICALS, INC. — Investor Relations & Filings

Ticker · ARWR ISIN · US04280A1007 LEI · 549300O3CSB8T7OZ3D66 US Manufacturing
Open in API
Filings indexed 1,039 across all filing types
Latest filing 2011-08-08 Regulatory Filings
Country US United States of America
Listing US ARWR

About ARROWHEAD PHARMACEUTICALS, INC.

https://arrowheadpharma.com/

Arrowhead Pharmaceuticals, Inc. is a biotechnology company that develops medicines to treat intractable diseases by silencing the genes that cause them. The company utilizes its proprietary RNA interference (RNAi) platform to create therapies that target disease pathways previously considered 'undruggable.' Arrowhead's development pipeline is focused on a broad range of therapeutic areas, including cardiometabolic, pulmonary, neuromuscular, and liver diseases. The company advances a portfolio of clinical-stage candidates designed to address significant unmet medical needs.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions that the company announced its first quarter financial results for the quarter ended June 30, 2011, and that a press release is furnished as an exhibit. The document itself does not contain detailed financial statements or substantive financial data but rather references a press release. The length of the document is 2757 characters, which is relatively short and consistent with an announcement rather than a full financial report. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not contain the full financial report or detailed analysis. It is not an Earnings Release (ER) because it does not contain the key highlights itself but references a press release. Therefore, the appropriate classification is Regulatory Filings (RNS).
2011-08-08 English
FORM 10-Q
Interim / Quarterly Report Q3 2011
2011-08-08 English
DEFINITIVE PROXY STATEMENT
Proxy Solicitation & Information Statement
2011-06-25 English
PRELIMINARY NOTICE & PROXY STATEMENT
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Preliminary Proxy Statement filed on Schedule 14A with the SEC, related to the Annual Meeting of Stockholders of Arrowhead Research Corporation. It includes detailed information about the meeting agenda, director nominations, voting procedures, and solicitation of proxies. The presence of the Schedule 14A form, the focus on proxy solicitation, director elections, and meeting logistics clearly identify this as a Proxy Solicitation & Information Statement. It is not an Annual Report, Earnings Release, or other financial report, but rather a document sent to shareholders to provide information and request votes for the meeting.
2011-06-15 English
FORM 8-K
Delisting Announcement Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The content specifically discusses a notice of deficiency from NASDAQ regarding the company's failure to meet the minimum bid price requirement and the potential for delisting if compliance is not regained. This matches the description of a Delisting Announcement. The document is short (2846 characters) and contains detailed information about the delisting risk and grace period, not just a reference or announcement of a report. Therefore, the correct classification is DLST (Delisting Announcement).
2011-06-09 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions that the company announced and commented on its financial results for the quarter ended March 31, 2011, and that a press release is furnished as an exhibit. The document is short (2738 characters) and primarily serves to announce the earnings release rather than containing detailed financial statements or analysis itself. According to the rules, initial announcements of quarterly financial results are classified as Earnings Release (ER). Therefore, this document is best classified as an Earnings Release (ER).
2011-05-12 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.